These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6364463)

  • 1. Naloxone administration to patients with acute stroke.
    Jabaily J; Davis JN
    Stroke; 1984; 15(1):36-9. PubMed ID: 6364463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose intravenous naloxone for the treatment of acute ischemic stroke.
    Olinger CP; Adams HP; Brott TG; Biller J; Barsan WG; Toffol GJ; Eberle RW; Marler JR
    Stroke; 1990 May; 21(5):721-5. PubMed ID: 2339451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of naloxone on acute stroke.
    Czlonkowska A; Cyrta B
    Pharmacopsychiatry; 1988 Mar; 21(2):98-100. PubMed ID: 3293092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of naloxone in the treatment of stroke].
    Zazzaro B; Russo G
    Recenti Prog Med; 1987 Nov; 78(11):512-3. PubMed ID: 3432729
    [No Abstract]   [Full Text] [Related]  

  • 5. A double blind trial of naloxone in the treatment of acute stroke.
    Fallis RJ; Fisher M; Lobo RA
    Stroke; 1984; 15(4):627-9. PubMed ID: 6087500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone.
    Hosobuchi Y; Baskin DS; Woo SK
    Science; 1982 Jan; 215(4528):69-71. PubMed ID: 6274019
    [No Abstract]   [Full Text] [Related]  

  • 7. Naloxone and mortality in the gerbil stroke model.
    Benzel EC; Musgrove CC; Kesterson L
    South Med J; 1989 May; 82(5):555-7. PubMed ID: 2717980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal cerebral ischemia in the cat: effect of naloxone on cortical blood flow and neurological deficit following middle cerebral artery occlusion.
    Levy R; Feustel P; Severinghaus J; Hosobuchi Y
    Bull Clin Neurosci; 1986; 51():94-101. PubMed ID: 3455250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke.
    Federico F; Lucivero V; Lamberti P; Fiore A; Conte C
    Ital J Neurol Sci; 1991 Dec; 12(6):557-63. PubMed ID: 1783533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone in stroke: worth a trial?
    Perey L; Mosimann B; Buchser E; Carroll R; Friedli P; Enrico JF; Rüedi B
    Crit Care Med; 1984 Jul; 12(7):614. PubMed ID: 6734233
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans.
    Hosobuchi Y; Baskin DS; Woo SK
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S98-100. PubMed ID: 7085809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of naloxone to reverse vascular neurologic deficits.
    Cutler JR; Bredesen DE; Edwards R; Simon RP
    Neurology; 1983 Nov; 33(11):1517-8. PubMed ID: 6685246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia.
    Adams HP; Olinger CP; Barsan WG; Butler MJ; Graff-Radford NR; Brott TG; Biller J; Damasio H; Tomsick T; Goldberg M
    Stroke; 1986; 17(3):404-9. PubMed ID: 3715936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute pulmonary edema after intravenous naloxone].
    Vitalone V; Lopresti C
    Minerva Anestesiol; 1992 Apr; 58(4):225-7. PubMed ID: 1620422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of neurological deficit with naloxone: an additional report.
    Hans P; Brichant JF; Longerstay E; Damas F; Remacle JM
    Intensive Care Med; 1992; 18(6):362-3. PubMed ID: 1469163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons.
    Baskin DS; Kieck CF; Hosobuchi Y
    Brain Res; 1984 Jan; 290(2):289-96. PubMed ID: 6692145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of naloxone in reducing postictal central respiratory dysfunction in patients with epilepsy: study protocol for a double-blind, randomized, placebo-controlled trial.
    Rheims S; Valton L; Michel V; Maillard L; Navarro V; Convers P; Bartolomei F; Biraben A; Crespel A; Derambure P; de Toffol B; Hirsch E; Kahane P; Martin ML; Tourniaire D; Boulogne S; Mercier C; Roy P; Ryvlin P;
    Trials; 2016 Nov; 17(1):529. PubMed ID: 27809868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Collins WF; Holford TR; Young W; Baskin DS; Eisenberg HM; Flamm E; Leo-Summers L; Maroon J
    N Engl J Med; 1990 May; 322(20):1405-11. PubMed ID: 2278545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone in septic shock.
    Groeger JS; Carlon GC; Howland WS
    Crit Care Med; 1983 Aug; 11(8):650-4. PubMed ID: 6307587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.
    Wong A; Macleod D; Robinson J; Koutsogiannis Z; Graudins A; Greene SL
    Clin Toxicol (Phila); 2015; 53(8):815-8. PubMed ID: 26109423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.